Additionally, except these immune checkpoints, we also noticed that most of immune checkpoints were associated positively with CCL2 level in GBM (Fig. 6B), suggesting that high CCL2 expression may be tightly related to immune suppressive status in GBM. This evidence concerns the gene CCL2 and glioblastoma.